Breast Neoplasm - Radiotherapy - Memorial Sloan Kettering Cancer Center - Phase 2 - All

Trial Radar AI Trial Candidate or Patient Patient Caregiver Healthcare Pro Biotech Pro Biotech Investor Researcher Other
	Let's discuss and explore clinical trials with Memorial Sloan Kettering Cancer Center as a lead sponsor or collaborator. Showing clinical trials for Breast Neoplasm. I can help you find clinical trials in specific locations and provide insights on health conditions and treatments. With advanced mode, access powerful pre-screening tools, interactive data visualizations, customized email alerts for trial updates and more.

Let's discuss and explore clinical trials with Memorial Sloan Kettering Cancer Center as a lead sponsor or collaborator.

Showing clinical trials for Breast Neoplasm.

I can help you find clinical trials in specific locations and provide insights on health conditions and treatments.

With advanced mode, access powerful pre-screening tools, interactive data visualizations, customized email alerts for trial updates and more.

Study Title	Status
A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer NCT05534438	Recruiting
Partial Breast Irradiation (PBI) Using 40 Gy for Select Patients With Early Invasive or Noninvasive Breast Cancer NCT01203839	Active, not recruiting
A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer NCT04683679	Recruiting
A Study of Surgery and Radiotherapy in People With Breast Cancer NCT07053085	Recruiting
Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer NCT04084730	Recruiting
Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung NCT03808662	Active, not recruiting
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease NCT03808337	Recruiting
Homologous Recombination Repair Status as a Biomarker of Response in Locally Recurrent/Metastatic Triple Negative Breast Cancer Patients Treated With Concurrent Cisplatin and Radiation Therapy NCT02422498	Active, not recruitingResults Posted

Clinical Trial Radar